Clinical Trial Update: Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing olmesartan/hydrochlorothiazide against an ACE inhibitor plus a calcium channel blocker for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ACE inhibitor + calcium channel blocker regimen
• olmesartan/hydrochlorothiazide (olmesartan; hydrochlorothiazide)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypertension | Phase 4 | Status: COMPLETED